Articles Archives - Page 2 of 791

TuesdayApr 14, 2026 9:45 am

Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) Builds Brazilian Rare Earth Platform Through Strategic Expansion

Disseminated on behalf of Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF)and may include paid advertising. The importance of magnet rare earths such as neodymium, praseodymium, dysprosium and terbium continues to grow as global electrification trends accelerate. Canamera Energy Metals is executing a strategy that goes beyond single-asset exploration. Canamera has initiated a 10-hole due diligence drilling program at Patos as it evaluates the acquisition of what would become its third ionic clay rare earth project in Brazil. The race to secure reliable supplies of magnet rare earth elements is accelerating as global demand rises across electric vehicles, renewable energy…

TuesdayApr 14, 2026 9:00 am

Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) Enters High-Growth Phase in Critical Minerals with 2026 Catalysts in Sight

Disseminated on behalf of Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) and may include paid advertising. Trilogy Metals’ joint venture, Ambler Metals, is taking steps to advance permitting, drilling, and feasibility milestones at its Arctic and Bornite projects in Alaska. Growing U.S. support for domestic critical mineral development is strengthening Trilogy’s position as a high-grade, multi-metal asset with increasing strategic value. Trilogy Metals (NYSE American: TMQ) (TSX: TMQ) is entering a critical phase in its evolution, with President and CEO Tony Giardini listing out a couple of near-term catalysts that could significantly progress the company’s flagship assets in Alaska’s Ambler…

TuesdayApr 14, 2026 9:00 am

QualityStocksNewsBreaks – Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) (FSE: 4LF0) Completes Due Diligence Auger Drill Program at Patos REE Project in Brazil

This article has been disseminated on behalf of Canamera Energy Metals Corp. and may include paid advertising. Canamera Energy Metals (CSE: EMET)(OTCQB: EMETF) (FSE: 4LF0) has completed its due diligence auger drill program at the Patos rare earth element project in Presidente Olegário, Minas Gerais, Brazil, with 11 holes totaling about 78 meters drilled between March 10 and March 26, 2026. The company submitted 66 samples to SGS Geosol in Vespasiano for multi-element analysis, including rare earth elements and titanium, with assay results expected in four to six weeks. The program is part of Canamera’s due diligence review tied to…

MondayApr 13, 2026 11:15 am

Safe Pro Group Inc. (NASDAQ: SPAI) Appoints Chief Operating Officer, Is Also Awarded Government Support Order for its Edge Processing Solution

Safe Pro Group, a developer of security and defense solutions, has appointed decorated SOCOM Joint Acquisition Task Force Commander Jarret Mathews as Chief Operating Officer. Mathews brings more than 25 years of experience to the table, with expertise in operational leadership, defense acquisition, and advanced technology integration. Safe Pro Group was also awarded a support contract for their AI Edge Processing solution contract awarded earlier by the U.S. Government. Safe Pro Group (NASDAQ: SPAI), a developer of AI-enabled defense, security, and situational awareness solutions, recently announced the appointment of Colonel (Ret.) Jarret Mathews as Chief Operating Officer (“COO”) (https://ibn.fm/7QDQk). Before…

MondayApr 13, 2026 10:30 am

LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) Nears Restart of Gold Production this Quarter with First Gold Pour on the Horizon

Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF)and may include paid advertising. Junior Canadian near-term gold producer LaFleur Minerals is positioned to restart operations at its Beacon Gold Mill in Canada’s prolific Abitibi Greenstone Belt LaFleur will use a bulk sample remaining from the previous company’s operations at its nearby Swanson Gold Project to produce its first gold pour, with the aim to increase the daily processing capacity of the mill over the next year Gold’s spot price has roughly doubled since January of last year and, although the price has fluctuated in response to geopolitical pressures…

MondayApr 13, 2026 9:45 am

MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Offers World’s First Voice-Enabled AI-Powered Drug and Alcohol Platform for Workplace Substance Abuse Screening

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF)and may include paid advertising. Workplace substance misuse costs U.S. employers over $81 billion annually through lost productivity, accidents, healthcare costs, and liability, with studies indicating that up to 40% of industrial workplace fatalities involve alcohol misuse. MindBio is introducing the world’s first AI-powered voice analytics system to detect drug and alcohol impairment in real time, initially targeting the South American mining sector, where heavy machinery and remote operations make safety monitoring critical. Such advanced screening technology has relevance to a global market spanning a range of safety-sensitive industries, including…

MondayApr 13, 2026 9:00 am

Rail Vision Ltd. (NASDAQ: RVSN) Targets Growing Billion-Dollar Train Safety Market with AI Obstacle Detection Systems

The global train collision avoidance system market is expected to reach $13.32 billion by 2030, growing at a compound annual growth rate (“CAGR”) of an estimated 15%. Rail Vision’s offerings have been described as AI-powered perception systems that allow rail operators to predict and prevent collisions. The company's two flagship products serve different operational environments but share the same underlying technological architecture. The global train collision avoidance market is undergoing a dramatic transformation, driven by the convergence of advanced camera systems and artificial intelligence. Rail Vision Ltd. (NASDAQ: RVSN, FSE: C80) is positioning itself squarely at the center of that…

FridayApr 10, 2026 11:15 am

Frontieras North America Inc. Unlocks Value in America’s Energy Future

Frontieras is developing breakthrough technologies that convert abundant solid hydrocarbons such as coal into cleaner fuels, hydrogen and industrial energy products. Central to this strategy is the company’s patented FASForm(TM) Solid Carbon Fractionation process. The company has not only developed its technology but is moving toward commercialization. Frontieras North America is emerging as a noteworthy innovator and attractive potential investment opportunity by addressing one of the most critical challenges facing modern technology: the rapidly growing demand for reliable, affordable electricity. As artificial intelligence (“AI”) and data-intensive computing expand, global electricity demand is projected to soar, with some analysts estimating AI-related…

FridayApr 10, 2026 10:30 am

SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) Advances Ukraine Defense Initiatives as Electronic Warfare Reshapes Battlefield

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF)and may include paid advertising. The war in Ukraine has demonstrated how electronic warfare can directly influence battlefield outcomes. The ability to interpret spatial data, maintain situational awareness and operate effectively in degraded signal environments is becoming increasingly important. SPARC AI has appointed a ground referral partner connected to Ukraine, a move intended to strengthen its engagement within the region and support potential deployment of its spatial intelligence capabilities. Electronic warfare has become one of the defining elements of modern conflict in Ukraine, where signal disruption, drone countermeasures and navigation…

FridayApr 10, 2026 9:45 am

LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Accelerates Cancer Care Innovation with Liora Technologies Acquisition and Leadership Expansion

LIXT is advancing its lead compound LB-100 across different clinical programs aimed at difficult-to-treat cancers The company’s acquisition of Liora Technologies introduces a complementary therapy platform with recurring revenue potential These updates underscore LIXTE’s broader strategy: integrating drug development and med-tech innovation to redefine cancer treatment LIXTE Biotechnology (NASDAQ: LIXT) is executing a differentiated strategy in oncology, extending beyond traditional drug development into a more integrated and multi-dimensional approach to cancer care. With the company’s lead clinical candidate, LB-100, advancing through trials and the addition of Liora Technologies to its platform, they are positioning themselves at the nexus of pharmaceutical…

Site Search

Company Search

Category: Articles